Avi B.

codeValet is a superhuman AI software engineer that accelerates enterprise software delivery through our deterministic approach. We break the AI code barrier by bringing logic back into the equation where other LLMs rely on statistical guesswork. Our patent-pending technology creates a trusted AI developer who works as a member of your team, delivering 10X productivity with reliable, executable code. codeValet processes millions of lines of code to provide context-aware insights beyond basic RAG, while delivering explainable solutions with direct references to your codebase. Built for secure enterprise environments, codeValet functions in private cloud, on-premise, or air-gapped systems with no context window limitations, ensuring your proprietary code and IP remain protected. Experience the difference of an AI engineer that truly understands, plans, and writes production-ready code.

Sinaptica Therapeutics™ is a Cambridge MA-based, clinical-stage company that has developed a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease (AD). The company was founded by two top clinical researchers in the field of noninvasive brain modulation for neurodegenerative disorders, together with support from biotech, digital health, and medical device industry executives. The company’s SinaptiStim™ System represents a totally new approach to treating AD by enhancing neuroplasticity via neurostimulation of key brain networks involved in memory, and has been granted FDA Breakthrough Designation based on unprecedented published Phase 2 sham-controlled data that achieved statistical significance on all four gold-standard cognitive & functional clinical endpoints. Sinaptica is building upon over a decade of research on innovative brain targeting methods, biophysical modeling, and noninvasive treatment protocols leveraging machine learning on proprietary datasets to create a foundational leap in personalized precision electromagnetic therapeutics. Based on highly significant published sham-controlled data, the companys neurostimulation device and integrated personalization engine has the potential to become one of the most clinically-effective treatments to reach Alzheimer’s patients in over two decades, and is protected by multiple pending patents.

Founded in 2000, Keiretsu Forum is the world’s largest angel investor network with over 2,500 accredited investor members throughout over 50 chapters on three continents.

Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI enabled, lung cancer decision support software to the mainstream market, driving the optimal clinical pathway for each patient. Reveal-Dx is a young company, started in early 2021, but we jump started the company by purchasing the assets of Mindshare Medical in March. Mindshare had invested millions of dollars and over 5 years of research developing core, patented algorithms that were actively being deployed in the clinic for validation.

Meat made from cells. We’re building the future you’re hungry for. *all meat shown is UPSIDE meat https://linktr.ee/upsidefoods Cultivated meat is new to many of us, and here at UPSIDE, we encourage education, learning, and fact-based debate. We ask that, in accordance with our values, you keep the conversation respectful to each other and to us. Thanks!

emberlight was founded to create simple and easy to use smart lighting. The emberlight smart socket, which turns any light into a smart light, launched on Kickstarter in July 2014, and was featured on CNET, Yahoo, TechCrunch, Huffington Post and Popular Mechanics. The product eventually made it to the shelves of Target stores nationwide, in addition to being sold online at Amazon, Best Buy, Home Depot and Target. Unfortunately, emberlight shutdown in November 2017.

Evergreen Vinyl is both a brick and mortar record store in Camas, WA and an ecommerce destination. We carry new and used vinyl, limited-edition pressings, and we’re an authorized reseller of Audio-Technica turntables.

codeValet is a superhuman AI software engineer that accelerates enterprise software delivery through our deterministic approach. We break the AI code barrier by bringing logic back into the equation where other LLMs rely on statistical guesswork. Our patent-pending technology creates a trusted AI developer who works as a member of your team, delivering 10X productivity with reliable, executable code. codeValet processes millions of lines of code to provide context-aware insights beyond basic RAG, while delivering explainable solutions with direct references to your codebase. Built for secure enterprise environments, codeValet functions in private cloud, on-premise, or air-gapped systems with no context window limitations, ensuring your proprietary code and IP remain protected. Experience the difference of an AI engineer that truly understands, plans, and writes production-ready code.

Sinaptica Therapeutics™ is a Cambridge MA-based, clinical-stage company that has developed a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease (AD). The company was founded by two top clinical researchers in the field of noninvasive brain modulation for neurodegenerative disorders, together with support from biotech, digital health, and medical device industry executives. The company’s SinaptiStim™ System represents a totally new approach to treating AD by enhancing neuroplasticity via neurostimulation of key brain networks involved in memory, and has been granted FDA Breakthrough Designation based on unprecedented published Phase 2 sham-controlled data that achieved statistical significance on all four gold-standard cognitive & functional clinical endpoints. Sinaptica is building upon over a decade of research on innovative brain targeting methods, biophysical modeling, and noninvasive treatment protocols leveraging machine learning on proprietary datasets to create a foundational leap in personalized precision electromagnetic therapeutics. Based on highly significant published sham-controlled data, the companys neurostimulation device and integrated personalization engine has the potential to become one of the most clinically-effective treatments to reach Alzheimer’s patients in over two decades, and is protected by multiple pending patents.